A novel reciprocal translocation associated with chronic eosinophilic leukemia

REFERENCES

• Brugnomi D, Afro P, Rossig G, Bettinardi A, Simon HU, Garza L, Tosoni C, Cattaneo R, Blaser K, Tucci A. A case of hypereosinophilia syndrome is associated with the expansion of a CD3-CD4 + T cell population able to secrete large amounts of interleukin 5. Blood 1996;87:315–317.
   Google Scholar
• Kitano K, Ichikawa N, Mahbub B, Uneo M, Ito T, Shimodaira S, Kodaira H, Ishida F, Kobayashi H, Saito H, et al. Eosinophilia associated with proliferation of CD3 + 4-8-alphabeta + T cells with chromosome 16 anomalies. Br J Haematol 1996;92:315–317.
   Google Scholar
• Simon UH, Lotz SG, Dummer R, Blaser K. Abnormals clones of T cells producing interleukin 5 in idiopathic eosinophilia. N Engl J Med 1999;341:1112–1120.
   Google Scholar
• Bath P, Pierre R, Imbert M, Vardiman JW, Brunning RD, Flandrin G. Chronic eosinophilia leukaemia and the hyper-eosinophilic syndrome. In: Jaffe ES, Harris NL, Stein H and Wardiman JW, editors. Classification of tumors, pathology and genetics of tumors of haematopoietic and lymphoid tissus. World Health Classification of Tumors. IARC Press. 2001.
   Google Scholar
• Weide R, Rieder H, Mehraein Y, Kaiser U, Seifart U, Gorg C, Havemann K. Chronic eosinophilic leukaemia (CEL): a distinct myeloproliferative disease. Br J Haematol 1997;96: 117— 123.
   Google Scholar
• Flaum MA, Schooley RT, Tauci AS, Gralnick HR. A clinicopathologic correlation of the idiopathic hypereosino-philic syndrome I- Hematologic manifestations. Blood 1981;58:1012–1020.
   Google Scholar
• Sanderson GJ. Interleukin 5, eosinophils and disease. Blood 1992;79:3101 —3109.
   Google Scholar
• Yam LT, Yam CF, Li CY. Eosinophilia in systemic mastosis. Am J Clin Pathol 1980;73:48–54.
   Google Scholar
• Prin I, Lepers S, Roumier AS. 2002. Hyperéosinophilies et syndromes hyperéosinophiliques. Encycl Méd Chir, Héma-tologie, 13-009-A-10,12p. Editions scientifiques et médicales Elsevier SAS Paris.
   Google Scholar
• Bain BJ. Eosinophilic leukaemias and the idiopathic hyper-eosinophilic syndrome. Br J Haematol 1996;95:2–9.
   Google Scholar
• O'Shea jj, Jaffe ES, Lane HL, MacDermott RP, Tauli AS. Peripheral T cell lymphoma presenting as hypereosinophilia with vasculitis. Clinical, pathologic and immunologic fea-tures. Am J Med 1987;82: 539–545.
   Google Scholar
• Samoszuk M, Nansen L. Detection of interleukin 5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 1990;75:13–16.
   Google Scholar
• Meeker TC, Hardy D, Willma C, Hoga T, Abrams J. Activation of the interleukin 3 gene by chromosome translocation in acute lymphocy-tic leukemia with eosinophi-lia. Blood 1990;76: 285–289.
   Google Scholar
• Knuutila S, Alitalo R, Ruutu T. Power of the MAC(mor-phology-antibody-chromosomes) method in distinguishing reactive and clonal cells: report of a patient with acute lymphatic leukaemia, eosinophilia and t(5;14). Genes Chro-mosomes Cancer 1993;8: 219–223.
   Google Scholar
• Delabesse E, Thomas C, Radford I, Valensi F, Macintyre E. Leucemie,origine d'un syn-drome hypereosinophilique d'ap-parence idiopathique. Hematologie 1996;1:423 —426.
   Google Scholar
• Parreira L, Tavares JC, Hibbin JA, Marsh JC, Marcus RE, Babapulle VB, Spry JC, Goldmann M, Catovsky D. Chromo-some and cell culture studies in eosinophilic leukaemia. Br J Haematol 1986;62:659— 669.
   Google Scholar
• Bigoni R. Cuneo A, Roberti MG, Milani R, Bardi A, Cavazzini F, Minotto C, Castoldi G. Cytogenetic and molecular cytogenetic characterization of 6 new cases of idiopathic hypereosinophilic syndrome. Haematologica 2000;85: 486–491.
   Google Scholar
• Brito-Babapulle F. Clonal eosinophilic disorders and the eosinophilic syndrome. Blood Rev 1997;11:129 —145.
   Google Scholar
• Chang HW, Leong KH, Koh DR, Lee SH. Clonality of isolated eosinophils in the hyper-eosinophilic syndrome. Blood 1999;93:1651–1657.
   Google Scholar
• Olivier JWW, Deol I, Morgan DL, Tonks VS. Chronic eosinophilic leukemia and hypereosinophilic syndromes. Proposal for classification, literature review, and report of a case with a unique chromosomal abnormality. Cancer Genet Cytogenet 1998;107:111–117.
   Google Scholar
• Sato H, Danbara M, Tamura M, Morita M. Eosinophilic leukemia with a t(2;5)(p23;q35) translocation. Br J Haematol 1994;87:404–406.
   Google Scholar
• Baranger L, Szapiro N, Gardais J, Hillion J, Derre J, Francois S, Blanchet 0, Boasson M, Berger R Translocation t(5;12)(q31-q33;p12-p13): a non-random translocation asso-ciated with a myeloid disorder with eosinophilia. Br J Haematol 1994;88:343— 347.
   Google Scholar
• Berkowicz M, Rosner E, Rechavi G, Mamon Z, Neuman Y, Ben Bassat I, Ramot B. Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12). A new association. Cancer Genet Cytogenet 1991;51: 277–278.
   Google Scholar
• Golub DG, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF factor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal trans-location. Cell 1994;77:307–316.
   Google Scholar
• Sternberg DW, Tomasson MH, Carroll M, Curley DP, Barker G, Caprio M, Wilbanks A, Kazlauskas D, Gilliland G. The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways. Blood 2001;98: 3390–3397.
   Google Scholar
• Martinelli G, Malagola M, Ottaviani E, Trabacchi G, Baccarani M. Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereo-sinophilic syndrome. Haematologica 2004;89: 236–237.
   Google Scholar
• Sterr EJ, Cross NC. Myeloproliferative disorders with translocations of chromosome5q31-35:role of the platelet-derived growth factor receptor beta. Acta Haematol 2002; 107(2):113–122.
   Google Scholar
• Guasch G, Birnbaum M, Pebusque MJ. Une nouvelle classe de syndromes myeloproliferatifs: he syndrome myeloprolifer-atif atypique 8p 12 lie au gene FGFRI. Hematologie 2003;9: 43–56.
   Google Scholar
• Yakushijin K, Murayama T, Miruno I, Sasa A, Koizumi T, Imoto S. Chronic eosinophilic leukemia with unique chromosomal abnormality,t(5;12)(q33;q22). Am J Hematol 2001;68(4):301 —302.
   Google Scholar
• Huret JL. Translocation t(12;21)(q24;q22). Atlas Genet Cytogenet Oncol Haematol February 2003. URL: http:// www.infobiogen.fr/services/chromcancer/anomalies/ t1221q24q22ID11268.htmll
   Google Scholar
• Andrieux J, Demory JL, Morel P, Plantier J, Dupriez B, Cailier MT, Bauters F, Lai JL. Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia. Cancer Genet Cyto-genet 2002;137(1):68 — 71.
   Google Scholar
• Apperley JF, Gardembas M, Melo JV, Russel-Jones R, Bain B, Baxter E, Chase A, Chessells JM, Colombat M, Dearden CE, et al. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet derived growth factor receptor beta. N Engl J Med 2002;347:481–487.
   Google Scholar
• Gleich GJ, Leiferman KM, Pardanami A, Tefferi A, Butterfield JH. Treatment of hypereosinophilic syndrome with imatinib mesylate. Lancet 2002;359:1577 —1578.
   Google Scholar
• Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinski L, Griffin JD, et al. A tyrosine kinase created by fusion of the PDGFRA and FIPILI genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. New Engl J Med 2003;348: 1201–1214.
   Google Scholar
• Bain B. The idiopathic hypereosinophilic syndrome and eosinophilic leukemias. Haematologica 2004;89:133–137.
   Google Scholar